XML 31 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 26, 2020
Sep. 28, 2019
Sep. 29, 2018
Operating activities:      
Net earnings $ 18,305,000 $ 94,819,000 $ 103,596,000
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation of fixed assets 49,830,000 45,225,000 42,939,000
Amortization of intangibles and deferred costs 3,218,000 3,385,000 3,538,000
Gains from disposals of property & equipment (303,000) (347,000) (912,000)
Plant shutdown impairment costs 6,387,000 0 0
Amortization of bond premiums 296,000 730,000 1,012,000
Share-based compensation 4,595,000 4,230,000 3,858,000
Deferred income taxes 2,622,000 9,637,000 (10,392,000)
Loss on sale of marketable securities 882,000 404,000 140,000
Changes in assets and liabilities, net of effects from purchase of companies:      
Decrease (increase) in accounts receivable, net 14,580,000 (8,759,000) (7,917,000)
Decrease (increase) in inventories 7,877,000 (3,231,000) (9,639,000)
Increase in prepaid expenses and other (11,366,000) (744,000) (1,120,000)
(Decrease) increase in accounts payable and accrued liabilities (4,780,000) 2,150,000 (1,736,000)
Net cash provided by operating activities 92,143,000 147,499,000 123,367,000
Investing activities:      
Payments for purchases of companies, net of cash acquired (57,212,000) (1,156,000) 0
Purchases of property, plant and equipment (57,817,000) (57,128,000) (60,022,000)
Purchases of marketable securities (6,103,000) (26,091,000) (91,112,000)
Proceeds from redemption and sales of marketable securities 73,226,000 39,158,000 75,302,000
Proceeds from disposal of property, plant and equipment 3,593,000 2,050,000 2,639,000
Other (150,000) (196,000) 54,000
Net cash used in investing activities (44,463,000) (43,363,000) (73,139,000)
Financing activities:      
Payments to repurchase common stock (8,972,000) 0 (2,794,000)
Proceeds from issuance of common stock 7,901,000 14,174,000 8,894,000
Payments on finance lease liabilities (340,000) (356,000) (370,000)
Payment of cash dividend (42,053,000) (36,644,000) (33,066,000)
Net cash used in financing activities (43,464,000) (22,826,000) (27,336,000)
Effect of exchange rates on cash and cash equivalents (802,000) (394,000) (2,375,000)
Net increase in cash and cash equivalents 3,414,000 80,916,000 20,517,000
Cash and cash equivalents at beginning of year 192,395,000 111,479,000 90,962,000
Cash and cash equivalents at end of year $ 195,809,000 $ 192,395,000 $ 111,479,000